Diabetes In India
- All
- News
- Videos
- Web Stories
-
Can Makhana Or Fox Nuts Keep You Full Without The Insulin Spike?
Makhana, or fox nuts, have the ability to keep you full for long hours. The key is to consume a controlled portion and in a form that maintains its nutritional integrity.
-
Indian Woman Shares Reality Of Losing 30 Kg With Ozempic: "Your Stomach Refuses To Cooperate"
She emphasised that the treatment is not a "shortcut" for weight management, noting it is a serious medication.
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Is Bariatric Surgery Too Extreme? Surgeon Explains Why This Obesity Treatment Still Matters
Bariatric surgery is called extreme far more often than obesity itself is. That imbalance reflects how this condition is still viewed, by the public and, at times, even within medicine.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Summer Heat And Dehydration Impact Oral Health: Dentist Explains
During the summer months, rising temperatures and increased fluid loss can have a noticeable impact on the condition of the mouth.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Sabudana Khichdi, Poha, Or Upma? Which Indian Breakfast Is Less Likely To Cause A Blood Sugar Spike
There are numerous Indian breakfast options like sabudana khichdi, poha, and upma. To effectively gauge which breakfast type is better at controlling your blood sugar, you need to look at their individual glycaemic index and the form they are made in
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
Recent Legionnaire's Disease Outbreaks In London, New York Raise Alarm: Is India At Risk?
Recent Legionnaires' disease outbreaks in cities like London and New York highlight growing public health risks linked to contaminated water systems. Here's what the disease is, why outbreaks occur, and what it means for countries like India.
-
Can Makhana Or Fox Nuts Keep You Full Without The Insulin Spike?
Makhana, or fox nuts, have the ability to keep you full for long hours. The key is to consume a controlled portion and in a form that maintains its nutritional integrity.
-
Indian Woman Shares Reality Of Losing 30 Kg With Ozempic: "Your Stomach Refuses To Cooperate"
She emphasised that the treatment is not a "shortcut" for weight management, noting it is a serious medication.
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Is Bariatric Surgery Too Extreme? Surgeon Explains Why This Obesity Treatment Still Matters
Bariatric surgery is called extreme far more often than obesity itself is. That imbalance reflects how this condition is still viewed, by the public and, at times, even within medicine.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Summer Heat And Dehydration Impact Oral Health: Dentist Explains
During the summer months, rising temperatures and increased fluid loss can have a noticeable impact on the condition of the mouth.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Sabudana Khichdi, Poha, Or Upma? Which Indian Breakfast Is Less Likely To Cause A Blood Sugar Spike
There are numerous Indian breakfast options like sabudana khichdi, poha, and upma. To effectively gauge which breakfast type is better at controlling your blood sugar, you need to look at their individual glycaemic index and the form they are made in
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
Recent Legionnaire's Disease Outbreaks In London, New York Raise Alarm: Is India At Risk?
Recent Legionnaires' disease outbreaks in cities like London and New York highlight growing public health risks linked to contaminated water systems. Here's what the disease is, why outbreaks occur, and what it means for countries like India.
